Summary In an attempt to enhance the anti-tumour immune response, the co-stimulatory molecules B7-1 or B7-2 were expressed on the surface of B16 melanoma cells. B7-expressing tumours grew more slowly in both syngeneic immunocompetent mice and athymic T cellimmunodeficient nude mice. The delay in growth of B7-expressing tumours was dependent on natural killer (NK) cells, as reductions in tumour growth rates were minimized in mice depleted of NK cells. Systemic immunity to B16 melanoma was examined by vaccination with irradiated tumour cells. Inoculation with irradiated B16 B7-1 cells failed to protect against a subsequent challenge with live parental B16 cells. but conferred partial protection against challenge with live B16 B7-1 cells. In contrast to the local anti-tumour reaction. this protective response was dependent on T cells. The results presented here reveal some of the mechanisms involved in the in vivo response to a poorty immunogenic tumour modified to express co-stimulatory molecules.
a potential therapeutic modality hax-e centred mainly on T cells. as these represent the immune cell population with antigen specificity and memon- (Tepper and Mule. 1994: Colombo and Fomi. 1996 ). An effectixe l-tic response against tumour cells requires actix ation of precytotoxic CD8-T cells bN-cvtokines secreted from CD4-T helper cells w hich. in tum. has-e been actix ated by professional antigyen-presenting cells (APCs) that hax-e taken up antigens denxied from tumour cells (Pardoll. 1993 ). In addition. professional APCs mav also actix ate CD8+ cvtotoxic T cells directlx (Huang et al. 1994) . Efficient acti-ation of T cells requires antigen-non-specific signals. as well as the antigyen-specific signal receix ed by the T-cell receptor/CD3 complex. An important costimulatorv signal is provided bx the CD28 receptor on T cells (Linslev and Ledbetter. 1993) . the ligands for which belong to the B7 familN. including B7-1 (CD80) ) and B7-2 )B70/CD86) (Azuma et al. 1993 : Freeman et al. 1993 . These costimulatorx molecules are expressed by professional APCs. such as dendritic cells and macrophages. enabling them to present antigens effectix-ely to T cells. Co-stimulatory signals give rise to increased expression of a Xaniety of cytokines that hax e autocnrne and paracrine effects on the proliferation. actixvation and maturation of T cells (Gimmi et al. 1991) . Recenved 26 September 1997 Revised 25 March 1998 Accepted 27 March 1998 Correspondence to: RG Vile In recent *-ears. it has become evident that many human and experimental tumours possess specific antigens that may be reco2-nized bv T cells and that may act as targets for an immune rejection response (Boon et al. 1994) . Such specific antigens haxe been identified in the B16 murine melanoma (Naftzger et al. 1996 : Bloom et al. 1997 . However. as most tumour cells do not express co-stimulatorv molecules. tumour-specific antigens w-ould fail to be presented to T cells efficiently. Indeed. this may represent one mechanism bv which tumour cells evade recognition by the immune system .
In x-itro. actixation of cytotoxic T cells may be achieved by stimulation via the TCR and CD28. without requirement for exo,genous cyvtokines provided by T helper cells (Azuma et al. 1992a: Harding, and Allison. 1993 shown that the in xivo response against some B7-1-expressing tumours is mediated primarily by natural killer (NK) cells. instead of (Geldhof et al. 1995 : Yeh et al. 1995 . or in addition to. T cells (Cavallo et al. 1995 : Wu et al. 1995 
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Cell cufture B16 is a long-established murine melanoma cell line (Fidler. 1970) . The B16.F1 subline was used in this studv. CMT93 is a murine colorectal tumour cell line (Franks and Hemmings. 1978) . All cell lines were monitored routinelv and found to be free of Ml coplasma infection. The cells were cultured in Dulbecco's modified Eagle's minimal essential medium supplemented x-ith 10% (vol/xol) fetal calf serum and 4 n-M L-glutamine.
Expression plasmids and transfection of tumour cells wr Subcloningxwas performed using standard recombinant techniques (Sambrook et al. 1989) . Plasmid pTyr-B7-1 is a tissue-specific expression xector where murine B7-1 is drixven by the 5' promoter of the murine tyrosinase gene Hart. 1993: Chong et al. 1996) . The expression vector BCMGSNeo-mB70 wvas kindly provided by Professor M Azuma (Tokyo) (Azuma et al. 1993 (Huang et al. 1996 : Cav'eux et al. 1997 . Indeed. the former mechanism may be more effective than direct presentation (Huang et al. 1996) .
We examined the abilitv of irradiated. 
Statistical analyses
Data from the animal experiments were analysed by plotting Kaplan-Meier curves using the *occurring event as the time at which a tumour appeared. A tumour was considered to be present when a palpable mass >0.2 cm was noted. Different groups of mice were compared using the log-rank test (Altman. 1991). (data not shown). In the experiment depicted in Figure 2A . Figure 4C ) but the difference t) (Figure 2A) . which in the B7-2 and parental lines was markedly diminished w%hen repeated experiments compared in anti-asialo GM 1-treated mice ( Figure 4D (1998) 78(8) (Lanier. 1997) . A family of receptors recognizes MHC class I molecules and aenerates an inhibitors signal to NK cells. In the mouse these belong to the L-49 family of proteins. whereas in humans this function is provided by the familv of killer cell inhibitory receptors (KIR) (Raulet. 1996) . Low expression of MHC class I by tumours such as B 16 melanoma leads to poor recognition by T cells. but may favour NK cell activation as MHC class I interacts with these inhibitorv molecules.
The stimulatory receptors on NK cells are not as w-ell understood. but a xarietx of different molecules are assumed to be responsible for this activity. One family of receptors w ith stimulatory activitv is NKR-P 1. w hich recognizes oligosaccharide moieties on tumour cells (Bezouska et al. 1994) . CD28. which is expressed on murine NK cells. also provides a stimulatory signal on binding with B7. promoting NK cell proliferation and increased cxtokine secretion (Nandi et al. 1994) . Recently'. B7-1 was reported to bind to an unidentified receptor on murine NK cells and trigger cvtolvtic activity (Chambers et al. 1996) . Moreover. this signal was able to oxerride the inhibitory signals imparted by MHC class I molecules. Human NK cell lines derixved from the YT line also express CD28. and the cytolytic actix itv of these cell lines is enhanced by the interaction of CD28 with B7 (Azuma et al. 1992b : Montel et al. 1995 . Moreoxer. fresh human NK cells haxe been found to lyse B7-1-expressing, tumour cells preferentiallx (Dessureault and Gallincer. 1996) .
Other groups have descnrbed X aried effects of B7-1 expression on in xixo growth of B16 melanoma. In some cases. B7-1 did not affect the growth pattern (Chen et al. 1994 : Townsend et al. 1994 . whereas in others it resulted in complete rejection of B 16 tumours. a response that was mediated by NK cells and CD8-cells (Wu et al. 1995) . These apparently conflicting results probably reflect differinm levels of B7-1 expression. as it has been reported that only clones expressing high levels of B7-1 were rejected completely. whereas low-expressing clones grew more slow-ly but were not rejected (Xu et al. 1995) . The results we present here are compatible with this possibility. The clone used in our experiments expressed a comparable level of B7-1 to the low-expressing clone in the latter study. Under in vitro conditions. B7-expressing, tumour cells w ere no more susceptible to lysis by fresh splenocy'tes than were the parental cells (data not shown). This does not correlate with the in xivo results. but may simply' reflect the less than ideal nature of the in X itro assay.
As well as the effects on local tumour growth. it is also of importance to determine the effects of B7 co-stimulatory molecules on systemic immunity'. In some studies. B7-expressing tumours have generated protectixe immunity against a subsequent challenre with parental tumour cells (Caxallo et al. 1995 : Gajewski et al. 1996 : Dunussi-Joannopoulos et al. 1996 although in other studies such tumours did not elicit any protective immunitv (Ramarathinam et al. 1994 : Katsanis et al. 1995 . Previously. in the moderately immunooenic tumour model (K1735 murine melanoma) we demonstrated that B7-expressing tumours may ex-en reduce the degree of systemic immunity relatixe to that elicited by the parental tumour (Chonc et al. 1996) (Zitvogel et al. 1996) .
Similarly. tumour-infiltratin, lymphocytes from a B7-expressing plasmacvtoma w-ere able to lyse the B7-expressing tumour cells.
but the parental tumour cells were lysed inefficientlI (Ramarathinam et al. 1994 In this report. we confirm reports by others that the local response against B7-1-expressing B16 melanoma is mediated. at least in part. by NK cells (Wu et al. 1995) . We have also shown that the reaction to the B7-2-expressing tumour is similar. and this constitutes the first report describing NK cells as the main effector cells responsible for an in vivo response against a B7-2-expressing tumour. The involvement of NK cells in the local response may help to explain the recent reports concerning the role of host APCs in production of systemic immunity. as elicited by B7-expressing tumour cells (Huang et al. 1996 : Cayeux et al. 1997 
